and global disruptions for the most critical drugs for life-saving and life-sustaining treatment. Outcomes of this research will improve the healthcare supply system's ability to maintain a steady and adequate supply of critical medicines and supplies worldwide. CIDRAP Leadership Forum Membership in the CIDRAP Leadership Forum (CLF) connects decisionmakers to intelligence they can trust when they need it most. The CLF is a high-value, highly responsive service offered by CIDRAP that ensures businesses and organizations have rapid access to critical intelligence on emerging infectious disease threats and public health issues. Members say CLF provides insight and analysis they cannot find easily elsewhere. CLF members connect with Michael T. Osterholm, an international authority on emerging infectious diseases, and the comprehensive team of CIDRAP experts through special communications, conference calls, webinars, and special CLF events. Past Initiatives Ebola Vaccine Team B Wellcome Trust and CIDRAP launched the Ebola vaccine Team B initiative in November 2014 to assist international efforts to develop in record time safe and effective vaccines against Ebola virus disease. The project includes 25 distinguished leaders in public health, medicine, bioethics, pharmaceutical manufacturing, and humanitarian relief. The experts provide a fresh perspective (a Team B analysis) of issues being addressed by international collaborators in the areas of funding, research, development, vaccine efficacy and effectiveness determination, licensure, manufacturing, and vaccination strategy (distribution and administration). To date, Team B has published its findings in the following reports: "Completing the Development of Ebola Vaccines: Current Status, Remaining Challenges, and Recommendations" "Plotting the Course of Ebola Vaccines: Challenges and Unanswered Questions" "Recommendations for Accelerating Development of Ebola Vaccines: Report and Analysis" "Fast-Track Development of Ebola Vaccines: Principles and Target Product Criteria" BioWatch CIDRAP has served as a partner in the federal BioWatch air-monitoring program. This program is responsible for the constant monitoring for potential bioterrorism-related agents in cities throughout the United States. Through its contract with the Department of Homeland Security, CIDRAP provides support for the development of national outdoor and indoor guidance documents, a national epidemiology communications network, and a suite of related program and reference documents. Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS) The Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS), established by the National Institutes of Health (NIH) and CIDRAP in April 2007, was one of six NIH-supported centers in the United States. The activities of the center, including research and surveillance both domestically and